Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

1,324

Participants

Timeline

Start Date

October 11, 2017

Primary Completion Date

August 27, 2021

Study Completion Date

August 27, 2026

Conditions
Hepatocellular Carcinoma
Interventions
DRUG

Durvalumab

Durvalumab IV (intravenous infusion).

DRUG

Tremelimumab (Regimen 1)

Tremelimumab IV (intravenous infusion).

DRUG

Tremelimumab (Regimen 2)

Tremelimumab IV (intravenous infusion).

DRUG

Sorafenib

Sorafenib, as per standard of care

DRUG

Durvalumab (Regimen 1)

Durvalumab IV (intravenous infusion).

DRUG

Durvalumab (Regimen 2)

Durvalumab IV (intravenous infusion).

Trial Locations (160)

3080

Research Site, Seoul

3722

Research Site, Seoul

5505

Research Site, Seoul

6351

Research Site, Seoul

10065

Research Site, New York

10408

Research Site, Ilsan

13620

Research Site, Seongnam-si

15237

Research Site, Pittsburgh

20007

Research Site, Washington D.C.

21231

Research Site, Baltimore

28262

Research Site, Charlotte

32224

Research Site, Jacksonville

33916

Research Site, Fort Myers

41944

Research Site, Daegu

48109

Research Site, Ann Arbor

49241

Research Site, Busan

55905

Research Site, Rochester

66205

Research Site, Westwood

74235

Research Site, Dallas

75216

Research Site, Dallas

75235

Research Site, Dallas

77030

Research Site, Houston

77090

Research Site, Houston

84107

Research Site, Murray

90048

Research Site, Los Angeles

92868

Research Site, Orange

94158

Research Site, San Francisco

97213

Research Site, Portland

Unknown

Research Site, Barretos

Research Site, Curitiba

Research Site, Florianópolis

Research Site, Porto Alegre

Research Site, Rio de Janeiro

Research Site, São Paulo

Research Site, Beijing

Research Site, Changchun

Research Site, Changsha

Research Site, Chengdu

Research Site, Dalian

Research Site, Fuzhou

Research Site, Guangzhou

Research Site, Hangzhou

Research Site, Harbin

Research Site, Hefei

Research Site, Nanchang

Research Site, Nanjing

Research Site, Nanning

Research Site, Shanghai

Research Site, Suzhou

Research Site, Wuhan

Research Site, Xi'an

Research Site, Zhengzhou

Research Site, Clichy

Research Site, Lille

Research Site, Marseille

Research Site, Montpellier

Research Site, Nancy

Research Site, Nantes

Research Site, Nice

Research Site, Pessac

Research Site, Poitiers

Research Site, Reims

Research Site, Rouen

Research Site, Saint-Etienne

Research Site, Toulouse

Research Site, Villejuif

Research Site, Aachen

Research Site, Cologne

Research Site, Essen

Research Site, Hanover

Research Site, Heidelberg

Research Site, Leipzig

Research Site, Mainz

Research Site, München

Research Site, Tübingen

Research Site, Ulm

Research Site, Hong Kong

Research Site, Bangalore

Research Site, Bhubneshwar

Research Site, Chennai

Research Site, Hubli

Research Site, Hyderabad

Research Site, Karmsad

Research Site, Mumbai

Research Site, Nashik

Research Site, New Delhi

Research Site, Benevento

Research Site, Meldola

Research Site, Milan

Research Site, Napoli

Research Site, Perugia

Research Site, Pisa

Research Site, Roma

Research Site, Rozzano

Research Site, Bunkyoku

Research Site, Chiba

Research Site, Fukuoka

Research Site, Hiroshima

Research Site, Iizuka

Research Site, Kanazawa

Research Site, Kōtoku

Research Site, Kumamoto

Research Site, Kurume

Research Site, Matsuyama

Research Site, Mitakashi

Research Site, Musashino

Research Site, Nagoya

Research Site, Okayama

Research Site, Osaka

Research Site, Ōgaki

Research Site, Ōsaka-sayama

Research Site, Saga

Research Site, Sapporo

Research Site, Shiwa

Research Site, Suntogun

Research Site, Tsu

Research Site, Yokohama

Research Site, Moscow

Research Site, Murmansk

Research Site, Nizhny Novgorod

Research Site, Novosibirsk

Research Site, Obninsk

Research Site, Omsk

Research Site, Saint Petersburg

Research Site, Ufa

Research Site, Barcelona

Research Site, Madrid

Research Site, Oviedo

Research Site, Pamplona Madrid

Research Site, Santander

Research Site, Chiayi City

Research Site, Kaohsiung City

Research Site, Taichung

Research Site, Tainan City

Research Site, Taipei

Research Site, Taoyuan District

Research Site, Bangkok

Research Site, Chang Mai

Research Site, Khon Kaen

Research Site, Phitsanulok

Research Site, Songkhla

Research Site, Dnipro

Research Site, IvanoFrankivsk

Research Site, Kharkiv

Research Site, Kropyvnitskyi

Research Site, Kyiv

Research Site, Lviv

Research Site, Odesa

Research Site, Uzhhorod

Research Site, Hanoi

Research Site, Hochiminh

T2N 4N2

Research Site, Calgary

T6G 1Z2

Research Site, Edmonton

L8V 5C2

Research Site, Hamilton

K7L 2V7

Research Site, Kingston

N6A 4L6

Research Site, London

M4N 3M5

Research Site, Toronto

H2X 0A9

Research Site, Montreal

G1R 2J6

Research Site, Québec

J1H 5N4

Research Site, Sherbrooke

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY